Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other ...

Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...

Awareness of auto-brewery syndrome is gradually increasing, but its recognition is still limited, which complicates diagnosis ...

Allergic conjunctivitis may be related to sleep disturbances in what may be a “self-perpetuating loop,” according to a poster ...

In this video, Jonathan A. Bernstein, MD, discusses an American College of Allergy, Asthma & Immunology Annual Scientific ...

Reframing women’s health care includes a greater emphasis on health span, and a closer look at ovarian aging, according to an ...

There is a tremendous unmet need for eye care in the world.According to WHO, more than 2 billion of the world’s 8 billion ...

With the expectations of friends and family to squeeze a high degree of activity and socialization into a short period of ...

A personalized alert tool improve use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for ...

In this video, Gailen D. Marshall Jr., MD, PhD, chair of allergy and immunology at University of Mississippi Medical Center, ...

In this video, Jonathan A. Bernstein, MD, discusses his American College of Allergy, Asthma & Immunology Annual Scientific ...

Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...